ARCHIVES

Biomarker Test Outperforms PSA and Gleason Score in Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

FY 1984 Bypass Budget Shown By Mechanism,, Research Program

July 2, 1982

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

In Brief: Three Comprehensive Centers Have Problems But Aren’t On “Probation”; Amos On Budget

June 9, 1978